๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

EXPRESSION OF PLASMINOGEN ACTIVATORS IN BASAL CELL CARCINOMA

โœ Scribed by SPIERS, ELIZABETH M.; LAZARUS, GERALD S.; LYONS-GIORDANO, BERNADETTE


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
809 KB
Volume
178
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

โœฆ Synopsis


The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively), have been identified in various malignancies and have been implicated in both local growth and metastatic spread. To characterize plasminogen activator expression more fully in human basal cell carcinoma, the localization of uPA and tPA mRNAs was evaluated by in situ hybridization. Nodular basal cell carcinomas demonstrated uPA expression in most cases, whereas the non-nodular subtypes were negative. Message for uPA was identified within tumour islands (11112 cases), scattered fibroblast-like stromal cells (6112 cases), and the basal layer of the overlying epidermis (10112 cases). In addition, signal for uPA was elevated and pronounced in areas where the epidermis merged into invasive basal cell carcinoma in the superficial papillary dermis in some cases. Message for uPA was often associated with ulceration or erosion of the overlying epithelium. Expression of tPA was noted in the epidermis (3112 cases) and in tumour cells (4112 cases), but tended to be focal and sparse. These results suggest that complex interactions involving uPA expression occur between the tumour, the stroma, and the overlying epidermis. Both the stroma and the epidermis may contribute to local spread of the tumour through production of uPA and consequent plasmin-mediated activation of collagenases and metalloproteinases.


๐Ÿ“œ SIMILAR VOLUMES


Plasminogen activators in oesophageal ca
โœ Mr D. F. Hewin; P. B. Savage; D. Alderson; M. N. Vipond ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 423 KB
Low levels of urokinase plasminogen acti
โœ T. Maguire; D. Chin; D. Soutar; M.J. Duffy ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 67 KB ๐Ÿ‘ 1 views

Basal cell carcinoma of the skin (BCC) is the most common cancer worldwide. Unlike most other human malignancies, BCCs rarely metastasise. In this investigation, we show that the serine protease urokinase plasminogen activator (u-PA), which is causally involved in metastasis, is expressed at lower l

Expression of plasminogen activators and
โœ Carsten Hรคckel; Bogdan Czerniak; Alberto G. Ayala; Kathrin Radig; Albert Roessne ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 474 KB ๐Ÿ‘ 1 views

## Background: The plasminogen activator system plays an important role in different malignant tumors. these enzymes participate in the destruction of intercellular matrices and basement membranes and/or can modulate the growth potency of tumor cells and may even promote metastases. in this study,

Plasminogen activators and their inhibit
โœ Hideo Wada; Yasurou Kumeda; Zin Ogasawara; Michiaki Ohiwa; Toshihiro Kaneko; Shi ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 359 KB ๐Ÿ‘ 1 views

Plasminogen activator (PA) and PA inhibitor (PAI) were measured in homogenates of leukemia cells. Both PA and PA1 levels were higher in non-lymphobiastic leukemia than in lymphobiastic leukemia. The levels were below the sensitivity of determination in chronic myeiocytic leukemia (CML) but showed si

TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR I
โœ WAGNER, STEPHAN N.; ATKINSON, MICHAEL J.; THANNER, STEPHANIE; SCHMITT, MANFRED; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 597 KB

In experimental models, plasminogen activator-mediated degradation of the extracellular matrix is inhibited by type-1 plasminogen activator inhibitor (PAI-1). PA14 has also been shown to protect tumour stromal tissue from autoproteolytic activities and may thus substantially promote tumour growth an

Expression of urokinase-type plasminogen
โœ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 488 KB ๐Ÿ‘ 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.